	销售		日
Acadia Pharmaceuticals	USD 307.96M	39.9M	2026-06
Adma Biologics	USD 114.5M	24.66M	2026-03
ALKERMES	USD 496.01M	103.1M	2026-06
Alterity Therapeutics Limited	AUD 596.04K	584.66K	2025-12
AstraZeneca	USD 15.38B	90M	2026-06
BioCryst Pharmaceuticals	USD 218.25M	188.3M	2026-06
Bristol-Myers Squibb	USD 12.97B	1.48B	2026-06
Cipla	INR 71.19B	5.78B	2026-06
Clal Biotechnology	ILS 3.41M	2M	2022-12
Compugen	USD 6.35M	60.98M	2026-03
CSL	USD 8.33B	4.79B	2025-12
Eli Lilly	USD 22.97B	3.17B	2026-06
GlaxoSmithKline	GBP 8.41B	781M	2026-06
Grifols	EUR 2B	306.7M	2026-03
Halozyme Therapeutics	USD 481M	104M	2026-06
Ionis Pharmaceuticals	USD 268M	22M	2026-06
J&J	USD 25.31B	1.21B	2026-06
Merck	USD 16.6B	310M	2026-06
Minerva Neurosciences	USD 0	0	2024-09
Neurocrine Biosciences	USD 959M	148M	2026-06
Novartis	USD 14.41B	1.3B	2026-06
Novavax	USD 147.14M	76.69M	2025-12
Pfizer	USD 15.03B	530M	2026-06
Roche Holding	CHF 30.36B	14.71B	2026-06
Sanofi	EUR 11.95B	710M	2026-06
Takeda	JPY 1.22T	130B	2026-06
Vanda Pharmaceuticals	USD 198.77M	151.12M	2024-12